166 related articles for article (PubMed ID: 30092444)
1. Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States.
Locham SS; Paracha N; Dakour-Aridi H; Nejim B; Rizwan M; Malas MB
Ann Vasc Surg; 2019 Feb; 55():55-62.e2. PubMed ID: 30092444
[TBL] [Abstract][Full Text] [Related]
2. Implementation of drug-eluting stents for the treatment of femoropopliteal disease provides significant cost-to-system savings in a single-state outpatient simulation.
Sridharan ND; Liang N; Robinson D; Avgerinos E; Tzeng E; Makaroun MS; Chaer RA; Eslami MH
J Vasc Surg; 2018 Nov; 68(5):1465-1472. PubMed ID: 29779962
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
Wakkie T; Konijn LCD; van Herpen NPC; Maessen MFH; Spreen MI; Wever JJ; Statius van Eps RG; Veger HT; van Dijk LC; Mali WPTM; van Overhagen H
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):376-381. PubMed ID: 31807849
[TBL] [Abstract][Full Text] [Related]
4. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.
Rodriguez AE; Rodriguez-Granillo AM; Antoniucci D; Mieres J; Fernandez-Pereira C; Rodriguez-Granillo GA; Santaera O; Rubilar B; Palacios IF; Serruys PW;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):385-94. PubMed ID: 22109997
[TBL] [Abstract][Full Text] [Related]
6. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions.
Zamani N; Sharath SE; Browder RC; Barshes NR; Braun JD; Mills JL; Kougias P; Younes HK
Ann Vasc Surg; 2021 Feb; 71():298-307. PubMed ID: 32891746
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis.
Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J
J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and cost of open versus endovascular repair of intact thoracoabdominal aortic aneurysm.
Locham S; Dakour-Aridi H; Nejim B; Dhaliwal J; Alshwaily W; Malas M
J Vasc Surg; 2018 Oct; 68(4):948-955.e1. PubMed ID: 29789217
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
Ding Y; Zhou M; Wang Y; Cai L; Shi Z
Ann Vasc Surg; 2018 Jul; 50():96-105. PubMed ID: 29514049
[TBL] [Abstract][Full Text] [Related]
12. Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.
Agarwal S; Sud K; Shishehbor MH
J Am Coll Cardiol; 2016 Apr; 67(16):1901-13. PubMed ID: 27012780
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
15. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
de Belder A; de la Torre Hernandez JM; Lopez-Palop R; O'Kane P; Hernandez Hernandez F; Strange J; Gimeno F; Cotton J; Diaz Fernandez JF; Carrillo Saez P; Thomas M; Pinar E; Curzen N; Baz JA; Cooter N; Lozano I; Skipper N; Robinson D; Hildick-Smith D;
J Am Coll Cardiol; 2014 Apr; 63(14):1371-5. PubMed ID: 24216285
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
20. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
